|
GB9801398D0
(en)
|
1998-01-22 |
1998-03-18 |
Anggard Erik E |
Chemical compounds
|
|
IT1301759B1
(it)
*
|
1998-06-19 |
2000-07-07 |
Nicox Sa |
Sali nitrati di farmaci antiipertensivi
|
|
IT1311923B1
(it)
|
1999-04-13 |
2002-03-20 |
Nicox Sa |
Composti farmaceutici.
|
|
IE20000052A1
(en)
*
|
1999-04-29 |
2000-11-29 |
Russinsky Ltd |
Nitric acid salts of B-blockers
|
|
IT1314184B1
(it)
*
|
1999-08-12 |
2002-12-06 |
Nicox Sa |
Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
|
|
EP1212053A4
(en)
|
1999-09-08 |
2004-08-11 |
Nitromed Inc |
METHODS FOR THE TREATMENT AND PROPHYLAXIS OF CONGESTIVE HEART FAILURE BY HYDRALAZIN COMPOUNDS AND ISOSORBIDE DINITRATE OR ISOSORBIDE MONONITRATE
|
|
US7537785B2
(en)
|
1999-10-29 |
2009-05-26 |
Nitromed, Inc. |
Composition for treating vascular diseases characterized by nitric oxide insufficiency
|
|
AU780261B2
(en)
|
1999-10-29 |
2005-03-10 |
Nitromed, Inc. |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
US7235237B2
(en)
|
1999-10-29 |
2007-06-26 |
Nitromed, Inc. |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
US7708989B2
(en)
|
1999-10-29 |
2010-05-04 |
Nitromed, Inc. |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
IL150368A0
(en)
*
|
1999-12-23 |
2002-12-01 |
Nitromed Inc |
Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use
|
|
AU3838901A
(en)
|
2000-02-16 |
2001-08-27 |
Illumina Inc |
Parallel genotyping of multiple patient samples
|
|
AU7007001A
(en)
|
2000-06-22 |
2002-01-02 |
Nitromed Inc |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
JP2004521083A
(ja)
*
|
2000-10-27 |
2004-07-15 |
ニトロメッド，インク． |
酸化窒素不足によって特徴づけられる血管疾患の治療方法
|
|
EP1219306A1
(en)
|
2000-12-29 |
2002-07-03 |
Nicox S.A. |
Compositions comprising cyclodextrins and NO- releasing drugs
|
|
ATE437637T1
(de)
|
2001-05-02 |
2009-08-15 |
Nitromed Inc |
Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
|
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
|
US20080026984A1
(en)
*
|
2002-02-04 |
2008-01-31 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
|
EP2042181A1
(en)
|
2002-02-04 |
2009-04-01 |
ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. |
Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
|
|
US7968605B2
(en)
*
|
2002-02-04 |
2011-06-28 |
ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
|
AU2003215240A1
(en)
|
2002-02-14 |
2003-09-04 |
Illumina, Inc. |
Automated information processing in randomly ordered arrays
|
|
CA2487414A1
(en)
*
|
2002-06-11 |
2003-12-18 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
US20060247216A1
(en)
*
|
2002-10-25 |
2006-11-02 |
Haj-Yehia Abdullah I |
Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
|
|
GB2395432B
(en)
*
|
2002-11-20 |
2005-09-14 |
Northwick Park Inst For Medica |
Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
|
|
US20060258652A1
(en)
*
|
2002-11-22 |
2006-11-16 |
Haj-Yehia Abdullah I |
Beta-blockers having antioxidant and no-donor activity
|
|
EP1578413A2
(en)
*
|
2002-11-29 |
2005-09-28 |
Yissum Research Development Company of The Hebrew University of Jerusalem |
Ace-inhibitors having antioxidant and no-donor activity
|
|
US20070207217A1
(en)
*
|
2003-02-03 |
2007-09-06 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release CO
|
|
US7166638B2
(en)
|
2003-05-27 |
2007-01-23 |
Nicox S.A. |
Statin derivatives
|
|
US7169805B2
(en)
|
2003-05-28 |
2007-01-30 |
Nicox S.A. |
Captopril derivatives
|
|
PL379197A1
(pl)
*
|
2003-06-19 |
2006-07-24 |
Nicox S.A. |
Nitroksylowe pochodne enalaprilu i pokrewne związki jako inhibitory ACE do leczenia chorób sercowo-naczyniowych
|
|
CA2536173A1
(en)
*
|
2003-08-20 |
2005-03-03 |
Nitromed, Inc. |
Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
|
|
AU2004294297A1
(en)
*
|
2003-12-02 |
2005-06-16 |
Nicox S.A. |
Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs
|
|
AP2006003622A0
(en)
*
|
2003-12-02 |
2006-06-30 |
Nicox Sa |
Nitrooxyderivatives of antihypertensive drugs
|
|
OA13356A
(en)
|
2004-01-05 |
2007-04-13 |
Nicox Sa |
Prostaglandin nitrooxyderivatives.
|
|
EP1778267A4
(en)
*
|
2004-07-16 |
2010-01-06 |
Nitromed Inc |
COMPOSITIONS AND METHODS RELATED TO HEART ERROR
|
|
JP2008510755A
(ja)
|
2004-08-25 |
2008-04-10 |
アクテリオン ファーマシューティカルズ リミテッド |
ビシクロノネン誘導体
|
|
US20080300292A1
(en)
*
|
2004-11-08 |
2008-12-04 |
Nitromed, Inc |
Nitrosated and Nitrosylated Compounds, Compositions and Methods for the Treatment of Ophthalmic Disorders
|
|
EP1846380A4
(en)
*
|
2005-01-21 |
2010-02-17 |
Nicox Sa |
HETEROCYCLIC NITROGEN MONOXIDE DONOR COMPOSITIONS CONTAINING CARDIOVASCULAR COMPOUNDS, AND METHODS OF USING THE SAME
|
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
|
JP4297972B2
(ja)
*
|
2005-05-27 |
2009-07-15 |
アクテリオン ファーマシューティカルズ リミテッド |
新規なピペリジンカルボン酸アミド誘導体
|
|
WO2007000641A2
(en)
*
|
2005-06-29 |
2007-01-04 |
Pfizer Inc. |
Prostaglandin derivatives
|
|
US20080274171A1
(en)
*
|
2005-10-18 |
2008-11-06 |
Nicoletta Almirante |
Renin Inhibitors Nitroderivatives
|
|
GB0601394D0
(en)
|
2006-01-24 |
2006-03-01 |
Hemocorm Ltd |
Therapeutic delivery of carbon monoxide
|
|
AU2007210813A1
(en)
|
2006-02-02 |
2007-08-09 |
Actelion Pharmaceuticals Ltd |
Secondary amines as renin inhibitors
|
|
WO2007097951A2
(en)
*
|
2006-02-17 |
2007-08-30 |
Nitromed, Inc. |
Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
|
|
AU2007224368A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Actelion Pharmaceuticals Ltd |
New amines
|
|
JP2007275193A
(ja)
*
|
2006-04-04 |
2007-10-25 |
Fujifilm Corp |
光プローブおよび光断層画像化装置
|
|
WO2007136626A1
(en)
*
|
2006-05-16 |
2007-11-29 |
Nitromed, Inc. |
Solid dosage formulations of hydralazine compounds
|
|
RU2322972C1
(ru)
*
|
2006-09-12 |
2008-04-27 |
Илья Николаевич Медведев |
Способ профилактики тромбозов у больных артериальной гипертонией с метаболическим синдромом
|
|
TW200831079A
(en)
*
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Angiotensin II receptor antagonists
|
|
FR2921365B1
(fr)
*
|
2007-09-21 |
2012-10-12 |
Servier Lab |
Nouveaux sels d'addition d'inhibiteurs d'enzyme de conversion de l'angiotensine a des acides donneurs de no, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
SG192543A1
(en)
|
2008-05-05 |
2013-08-30 |
Merck Canada Inc |
3, 4 - substituted piperidine derivatives as renin inhibitors
|
|
WO2010116270A1
(en)
|
2009-04-10 |
2010-10-14 |
Pfizer Inc. |
Ep2/4 agonists
|
|
WO2011160974A2
(en)
|
2010-06-21 |
2011-12-29 |
Nicox S.A. |
Statin derivatives
|
|
US9163044B2
(en)
|
2011-04-19 |
2015-10-20 |
Alfama, Inc. |
Carbon monoxide releasing molecules and uses thereof
|
|
JP6134710B2
(ja)
|
2011-07-21 |
2017-05-24 |
アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． |
一酸化ルテニウム放出分子およびその使用
|
|
WO2014111957A1
(en)
|
2013-01-21 |
2014-07-24 |
Apparao Satyam |
Nitric oxide releasing prodrugs of therapeutic agents
|
|
WO2018087092A1
(en)
|
2016-11-08 |
2018-05-17 |
Bausch & Lomb Incorporated |
Nitric oxide releasing prostaglandin derivatives for treating normal tension glaucoma
|
|
JP7775080B2
(ja)
|
2019-07-01 |
2025-11-25 |
トニックス ファーマ リミテッド |
抗ｃｄ１５４抗体およびその使用
|
|
US20240059781A1
(en)
|
2021-01-06 |
2024-02-22 |
Tonix Pharma Limited |
Methods of inducing immune tolerance with modified anti-cd154 antibodies
|
|
CN118146175A
(zh)
*
|
2024-02-07 |
2024-06-07 |
广州楷石生物科技有限公司 |
右旋噻吗洛尔衍生物及其制备方法和应用
|
|
WO2025248134A1
(en)
|
2024-05-31 |
2025-12-04 |
Tonix Pharma Limited |
Treatment methods comprising administration of modified cd154 antibodies
|